These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 7848348)

  • 1. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.
    Monopoli A; Conti A; Dionisotti S; Casati C; Camaioni E; Cristalli G; Ongini E
    Arzneimittelforschung; 1994 Dec; 44(12):1305-12. PubMed ID: 7848348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
    Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
    Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit.
    Sandoli D; Chiu PJ; Chintala M; Dionisotti S; Ongini E
    Eur J Pharmacol; 1994 Jun; 259(1):43-9. PubMed ID: 7957592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart.
    Lozza G; Conti A; Ongini E; Monopoli A
    Pharmacol Res; 1997 Jan; 35(1):57-64. PubMed ID: 9149317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
    Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
    J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.
    Casati C; Forlani A; Lozza G; Monopoli A
    Pharmacol Res; 1997 Jan; 35(1):51-5. PubMed ID: 9149316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
    De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
    Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
    Dionisotti S; Conti A; Sandoli D; Zocchi C; Gatta F; Ongini E
    Br J Pharmacol; 1994 Jun; 112(2):659-65. PubMed ID: 8075885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
    Felsch A; Stöcker K; Borchard U
    Eur J Pharmacol; 1994 Oct; 263(3):261-8. PubMed ID: 7843263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats.
    Casati C; Monopoli A; Forlani A; Bonizzoni E; Ongini E
    J Pharmacol Exp Ther; 1995 Nov; 275(2):914-9. PubMed ID: 7473182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
    Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial adenosine A1-receptor sensitivity during juvenile and adult stages of maturation.
    Sawmiller DR; Fenton RA; Dobson JG
    Am J Physiol; 1998 Feb; 274(2):H627-35. PubMed ID: 9486267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the novel non-xanthine heterocyclic compound GU285 as a potent non-selective adenosine receptor antagonist in the rat.
    Harden FA; Brown L; Quinn RJ; Harrison GJ; Headrick JP; Rose'Meyer RB; Willis RJ
    Arzneimittelforschung; 2002; 52(3):175-81. PubMed ID: 11963644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues.
    Conti A; Monopoli A; Gamba M; Borea PA; Ongini E
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):108-12. PubMed ID: 8377834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-response relationships for adenosine agonists during preconditioning of rabbit cardiomyocytes.
    Rice PJ; Armstrong SC; Ganote CE
    J Mol Cell Cardiol; 1996 Jun; 28(6):1355-65. PubMed ID: 8782077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium.
    Lasley RD; Kristo G; Keith BJ; Mentzer RM
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H426-31. PubMed ID: 16980350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine receptor agonists: synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA.
    Camaioni E; Di Francesco E; Vittori S; Volpini R; Cristalli G
    Bioorg Med Chem; 1997 Dec; 5(12):2267-75. PubMed ID: 9459024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1 receptors.
    Bryan PT; Marshall JM
    J Physiol; 1999 Jan; 514 ( Pt 1)(Pt 1):151-62. PubMed ID: 9831723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.
    De Sarro G; De Sarro A; Di Paola ED; Bertorelli R
    Eur J Pharmacol; 1999 Apr; 371(2-3):137-45. PubMed ID: 10357250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.